BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20615056)

  • 21. Plaques, tangles, and memory loss in mouse models of neurodegeneration.
    Eriksen JL; Janus CG
    Behav Genet; 2007 Jan; 37(1):79-100. PubMed ID: 17072762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA damage and impairment of DNA repair in Alzheimer's disease.
    Obulesu M; Rao DM
    Int J Neurosci; 2010 Jun; 120(6):397-403. PubMed ID: 20504209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurofibrillary pathology and aluminum in Alzheimer's disease.
    Shin RW; Lee VM; Trojanowski JQ
    Histol Histopathol; 1995 Oct; 10(4):969-78. PubMed ID: 8574016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Perspectives in immunotherapy of Alzheimer's disease].
    Rossi G
    Recenti Prog Med; 2003; 94(7-8):305-8. PubMed ID: 12868235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
    Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
    Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
    Pei JJ; Sjögren M; Winblad B
    Curr Opin Psychiatry; 2008 Nov; 21(6):555-61. PubMed ID: 18852562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathological and biochemical alterations of astrocytes in ovariectomized rats injected with D-galactose: a potential contribution to Alzheimer's disease processes.
    Hua X; Lei M; Ding J; Han Q; Hu G; Xiao M
    Exp Neurol; 2008 Apr; 210(2):709-18. PubMed ID: 18289535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel approaches for immunotherapeutic intervention in Alzheimer's disease.
    Vasilevko V; Cribbs DH
    Neurochem Int; 2006 Jul; 49(2):113-26. PubMed ID: 16765487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular vulnerability in brain aging and Alzheimer's disease. Clinical correlates and molecular background.
    Giannakopoulos P; Gold G; Michel JP; Bouras C
    Ann Med Interne (Paris); 1998 Jun; 149(4):187-91. PubMed ID: 11490545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular toxicity of aluminium in relation to neurodegeneration.
    ; Vasudevaraju P; Govindaraju M; Palanisamy AP; Sambamurti K; Rao KS
    Indian J Med Res; 2008 Oct; 128(4):545-56. PubMed ID: 19106446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anatomical and functional phenotyping of mice models of Alzheimer's disease by MR microscopy.
    Benveniste H; Ma Y; Dhawan J; Gifford A; Smith SD; Feinstein I; Du C; Grant SC; Hof PR
    Ann N Y Acad Sci; 2007 Feb; 1097():12-29. PubMed ID: 17413006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models.
    Reddy PH; McWeeney S
    Neurobiol Aging; 2006 Aug; 27(8):1060-77. PubMed ID: 16157420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Advances in molecular pathology of Alzheimer's disease].
    Coria-Balanzat F
    Rev Neurol; 2006 Mar 1-15; 42(5):306-9. PubMed ID: 16538595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropathological verisimilitude in animal models of Alzheimer's disease: key to elucidating neurodegenerative pathways and identifying new targets for drug discovery.
    Trojanowski JQ
    Am J Pathol; 2002 Feb; 160(2):409-11. PubMed ID: 11839559
    [No Abstract]   [Full Text] [Related]  

  • 35. Zebrafish as a tool in Alzheimer's disease research.
    Newman M; Verdile G; Martins RN; Lardelli M
    Biochim Biophys Acta; 2011 Mar; 1812(3):346-52. PubMed ID: 20920580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First magenetic resonance imaging studies on aluminium maltolate-treated aged New Zealand rabbits: an Alzheimer's animal model.
    Magisetty O; Dowlathabad MR; Raichurkar KP; Mannar SN
    Psychogeriatrics; 2016 Jul; 16(4):263-7. PubMed ID: 26419490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altering mitochondrial dysfunction as an approach to treating Alzheimer's disease.
    Colca JR; Feinstein DL
    Adv Pharmacol; 2012; 64():155-76. PubMed ID: 22840747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer's disease: transgenic models to test new chemicals and pharmaceuticals.
    Miller CC; Anderton BH
    Curr Opin Biotechnol; 1992 Dec; 3(6):683-6. PubMed ID: 1369125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Animal model for Alzheimer's disease].
    Takashima A; Chui D
    Nihon Rinsho; 2004 Apr; 62 Suppl 4():240-7. PubMed ID: 15174678
    [No Abstract]   [Full Text] [Related]  

  • 40. [Toward a better understanding of Alzheimer's disease].
    Lambert JC
    Soins Gerontol; 2010; (85):40-1. PubMed ID: 21137496
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.